2c7u: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
<StructureSection load='2c7u' size='340' side='right'caption='[[2c7u]], [[Resolution|resolution]] 2.38Å' scene=''> | <StructureSection load='2c7u' size='340' side='right'caption='[[2c7u]], [[Resolution|resolution]] 2.38Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2c7u]] is a 6 chain structure with sequence from [ | <table><tr><td colspan='2'>[[2c7u]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2C7U OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2C7U FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.38Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2c7u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2c7u OCA], [https://pdbe.org/2c7u PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2c7u RCSB], [https://www.ebi.ac.uk/pdbsum/2c7u PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2c7u ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
| Line 14: | Line 12: | ||
<jmolCheckbox> | <jmolCheckbox> | ||
<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/c7/2c7u_consurf.spt"</scriptWhenChecked> | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/c7/2c7u_consurf.spt"</scriptWhenChecked> | ||
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/ | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
</jmolCheckbox> | </jmolCheckbox> | ||
| Line 31: | Line 29: | ||
==See Also== | ==See Also== | ||
*[[Beta-2 microglobulin 3D structures|Beta-2 microglobulin 3D structures]] | *[[Beta-2 microglobulin 3D structures|Beta-2 microglobulin 3D structures]] | ||
*[[MHC 3D structures | *[[MHC 3D structures|MHC 3D structures]] | ||
*[[MHC I 3D structures|MHC I 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Homo sapiens]] | ||
[[Category: Human immunodeficiency virus 1]] | |||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Armitage | [[Category: Armitage AE]] | ||
[[Category: Beattie | [[Category: Beattie T]] | ||
[[Category: Buus | [[Category: Buus S]] | ||
[[Category: Chotiyarnwong | [[Category: Chotiyarnwong P]] | ||
[[Category: Christie | [[Category: Christie N]] | ||
[[Category: Dong | [[Category: Dong T]] | ||
[[Category: Fugger | [[Category: Fugger JL]] | ||
[[Category: Iversen | [[Category: Iversen AK]] | ||
[[Category: Jones | [[Category: Jones EY]] | ||
[[Category: Kaul | [[Category: Kaul R]] | ||
[[Category: Klarlund-Pedersen | [[Category: Klarlund-Pedersen B]] | ||
[[Category: Learn | [[Category: Learn GH]] | ||
[[Category: Lee | [[Category: Lee JK]] | ||
[[Category: Li | [[Category: Li Y]] | ||
[[Category: Luscher | [[Category: Luscher MA]] | ||
[[Category: MacDonald | [[Category: MacDonald K]] | ||
[[Category: McMichael | [[Category: McMichael AJ]] | ||
[[Category: Mullins JI]] | |||
[[Category: Mullins | [[Category: Skinhoj P]] | ||
[[Category: Skinhoj | [[Category: Stewart-Jones G]] | ||
[[Category: Stewart-Jones | [[Category: Sylvester-Hviid C]] | ||
[[Category: Sylvester-Hviid | [[Category: Ullum H]] | ||
[[Category: Ullum | [[Category: Xu X]] | ||
[[Category: Xu | [[Category: Van der Merwe PA]] | ||
[[Category: | |||
Latest revision as of 03:49, 21 November 2024
Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant HIV epitope.Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant HIV epitope.
Structural highlights
Evolutionary Conservation Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedCytotoxic T lymphocytes (CTLs) are critical for the control of human immunodeficiency virus, but containment of virus replication can be undermined by mutations in CTL epitopes that lead to virus escape. We analyzed the evolution in vivo of an immunodominant, HLA-A2-restricted CTL epitope and found two principal, diametrically opposed evolutionary pathways that exclusively affect T cell-receptor contact residues. One pathway was characterized by acquisition of CTL escape mutations and the other by selection for wild-type amino acids. The pattern of CTL responses to epitope variants shaped which variant(s) prevailed in the virus population. The pathways notably influenced the amount of plasma virus, as patients with efficient CTL selection had lower plasma viral loads than did patients without efficient selection. Thus, viral escape from CTL responses does not necessarily correlate with disease progression. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope.,Iversen AK, Stewart-Jones G, Learn GH, Christie N, Sylvester-Hviid C, Armitage AE, Kaul R, Beattie T, Lee JK, Li Y, Chotiyarnwong P, Dong T, Xu X, Luscher MA, MacDonald K, Ullum H, Klarlund-Pedersen B, Skinhoj P, Fugger L, Buus S, Mullins JI, Jones EY, van der Merwe PA, McMichael AJ Nat Immunol. 2006 Feb;7(2):179-89. Epub 2006 Jan 1. PMID:16388312[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||